Q1 2021 Holdings
Filed 2021-05-12 | 35 holdings | $326.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $305.0M | 10,542,790 | 93.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $17.5M | 696,000 | 5.4% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $2.7M | 293,500 | 0.8% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $218.9K | 5,827,415 | 0.1% |
| Passage BIO Inc | COM | 702712100 | $87.6K | 5,009,219 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $70.7K | 3,566,912 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $69.0K | 895,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $61.8K | 1,917,157 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $45.6K | 2,309,554 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $41.6K | 1,312,999 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $36.0K | 2,182,789 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $33.4K | 3,123,107 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $32.1K | 1,435,045 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $27.3K | 2,571,450 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $22.8K | 1,001,421 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.4K | 899,700 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $17.3K | 1,374,047 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $15.7K | 2,544,500 | 0.0% |
| Frazier Lifesciences Acqu Co | UNIT 12/09/2025 | G3710A121 | $15.3K | 1,501,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $14.2K | 1,437,028 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $12.0K | 351,954 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $9.7K | 1,030,878 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $9.6K | 3,190,079 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $9.2K | 316,616 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.1K | 508,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $7.9K | 156,000 | 0.0% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $6.8K | 550,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $6.4K | 739,369 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $5.2K | 578,104 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $4.9K | 1,296,743 | 0.0% |
| Allena Pharmaceuticals(ALNAEUR) | COM | 018119107 | $4.6K | 3,330,373 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $3.5K | 202,803 | 0.0% |
| Iterum Therapeutics PLC | SHS | G6333L101 | $2.2K | 1,538,316 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $2.1K | 241,000 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637113 | $707 | 425,650 | 0.0% |